Turenne Groupe
Also known as Turenne Capital, Turenne Capital Partenaires, TURENNE CAPITAL PARTENAIRES SA, Groupe Turenne
Employee-owned French small-cap private equity group founded in 1999 (Paris plus six regional offices); over €2bn under management (June 2026) in health, energy, hospitality, industry, deeptech.
- HEADQUARTERS
- Paris, France
- FOUNDED
- 1999
- AUM
- €2B (2026)
- OUTSIDE CAPITAL
- Yes
- TEAM LISTED
- 8 people
Focus
- STAGES
- SeedSeries AGrowthBuyout
- ASSET MIX
- Private equityVenture capitalDirect investments
- GEOGRAPHY
- France
Investment arms & vehicles
- Group venture capital company for deeptech and industrial startups (Innovacom Gestion, AMF GP 00017), acquired by Turenne Groupe in 2018
- Lille-based subsidiary of Turenne Groupe and Crédit Agricole Nord de France (AMF GP 10000039) investing in Hauts-de-France SMEs
- Turenne SantéHealthcare investment business of Turenne Groupe (Capital Santé funds, Next Health Capital)
- Marseille-based development/transmission manager acquired 2022
Overview
Turenne Groupe, founded in 1999 as Turenne Capital, invests equity in start-ups, SMEs and mid-caps across France through innovation capital, development capital and ownership-transition deals. In 2026 it reported more than €2bn of assets under management, over 300 portfolio companies, 85 staff and offices in Paris, Lille, Lyon, Marseille, Nice, Bordeaux and Nantes; it is 100% owned by its employees and became a société à mission in 2023. It runs sector teams in healthcare (Turenne Santé), energy and environment, hospitality, industry and deeptech start-ups (Innovacom, acquired 2018), plus regional funds and vehicles for private clients. In September 2026 Turenne Santé raised the target of Capital Santé 3 to €275M after passing its €250M hard cap.
Investment thesis
Small-cap generalist with sector teams: minority and majority development and buyout deals in profitable SMEs (Capital Santé 3: €10M–€30M tickets in French and European healthcare SMEs), regional growth funds, and venture investments in deeptech and industrial start-ups.
PORTFOLIO (12)
- DestiaNOTABLEHealthTech · since 2026
- La Foir’FouilleNOTABLEConsumer & E-commerce
- Tampopo GroupConsumer & E-commerce · since 2026
- MIR – Medical International ResearchHealthTech
- VedaLabHealthTech
- 02DClimate & Energy
- Le Petit SoukConsumer & E-commerce
- KizeoSoftware & SaaS
- Groupe Colibri – Promesse de FleursConsumer & E-commerce
- Ventuno BiotechBiotech & Life Sciences
- KimialysDeep Tech
- Pixee MedicalHealthTech
People
- Christophe DeldyckePrésident · source
- Benoît PastourAssocié · source
- Alexis DupontSecrétaire Général · source
- Mounia ChaouiDirectrice Générale Déléguée – Santé · source
- Anne-Sophie MaesDirectrice générale de Nord Capital Partenaires · source
- Stéphane SaudoDirecteur Associé · source
- Pauline BecqueyDirectrice ESG · source
- Julie RecaldeDirectrice Administrative & Financière · source
Links
Frequently asked questions
Turenne Groupe is a private equity fund based in Paris, France, founded in 1999.
Turenne Groupe invests directly in companies. Capital origin: third-party capital (fund LPs). Stated strategies include private equity, venture capital and direct investments.
Turenne Groupe invests at Seed, Series A, Growth and Buyout stages in HealthTech, Climate & Energy, Industrial & Manufacturing, Deep Tech and Consumer & E-commerce.
Turenne Groupe's stated ticket size is €10M–€30M.
Key people at Turenne Groupe include Christophe Deldycke (Président), Benoît Pastour (Associé), Alexis Dupont (Secrétaire Général) and Mounia Chaoui (Directrice Générale Déléguée – Santé).
Turenne Groupe's disclosed portfolio companies include Destia, La Foir’Fouille, Tampopo Group, MIR – Medical International Research, VedaLab, 02D, Le Petit Souk and Kizeo, among others.
The most recent publicly reported investment by Turenne Groupe is Tampopo Group (Growth capital (mainly primary) via Pays de la Loire Croissance 2), announced in Jun 2026.
Turenne Groupe states that it accepts submissions through its official contact page.